2023
DOI: 10.1001/jamaophthalmol.2022.6542
|View full text |Cite
|
Sign up to set email alerts
|

Eyeing a Role for Artificial Intelligence in Clinical Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…One potential application could be clinical trials for rare conditions, such as Retinitis pigmentosa. The rarity of such conditions often makes it challenging to conduct traditional clinical trials due to the lack of a large patient sample or ethical issues [51]. However, with the generation of multiple DTs reproducing the specifics of these rare diseases, it would become possible to test new treatments within a digital environment.…”
Section: Case Study: Developing a Dt Of The Eyementioning
confidence: 99%
“…One potential application could be clinical trials for rare conditions, such as Retinitis pigmentosa. The rarity of such conditions often makes it challenging to conduct traditional clinical trials due to the lack of a large patient sample or ethical issues [51]. However, with the generation of multiple DTs reproducing the specifics of these rare diseases, it would become possible to test new treatments within a digital environment.…”
Section: Case Study: Developing a Dt Of The Eyementioning
confidence: 99%